We found no group difference between bipolar disorder patients and controls with respect to total or phosphorylated tau (T-tau/P-tau) that reflect axonal damage and neurofibrillary degeneration [18], or Aβ1–42 that indicate plaque deposition [19]. This evidence concerns the gene MAPT and bipolar disorder.